课题基金 / 基金详情

Prolactin and Growth Hormone Family 2008 Gordon Research Conference

Prolactin and Growth Hormone Family 2008 Gordon Research Conference
催乳素和生长激素家族 2008 年戈登研究会议
批准号:
7474529
负责人:
HALLGEIR RUI
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2009-07-31

项目摘要

项目成果

HALLGEIR RUI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The 2008 Prolactin and Growth Hormone Gordon Research Conference will provide a forum for the presentation and active discussion of the most cutting-edge information and ideas on Prolactin, Growth Hormone and related peptides. The Gordon Research Conference format will bring together investigators that are international leaders in the structural, biochemical, cell signaling, physiological, developmental and clinicalpathological aspects of these hormone ligands and their receptors. We expect that this conference will provide a thorough and in-depth coverage of prolactin and growth hormone biology, thus continuing the tradition of this being the premier meeting in this field. The peptide ligands and receptors for PRL and GH have been shown to mediate critical biological actions related to reproduction and growth, respectively. However, PRL has now been documented to also affect many nonreproductive targets, such as modulating behavior, promoting neurogenesis, inducing tumorigenesis, regulating angiogenesis and bone formation, and impacting the immune system. Similarly, GH biology extends beyond its classical IGF-1-stimulatory and growth-promoting effects. Indeed, the GH/IGF-1 system has been implicated in carcinogenesis, cellular maintenance and repair, and longevity/aging pathways. While these recent advances have provided important insights into PRL and GH actions, nevertheless the precise mechanisms by which these two hormones mediate their effects remain unanswered. We encourage investigators at all career stages interested in these areas to attend the PRL and Growth Hormone GRC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prolactin pathways and metastatic progression of ER-positive breast cancer
  • 批准号:
    9178131
  • 项目类别:
  • 资助金额:
    $36.29万
  • 财政年份:
    2015
  • 负责人:
    HALLGEIR RUI
  • 依托单位:
Prolactin pathways and metastatic progression of ER-positive breast cancer
  • 批准号:
    9042998
  • 项目类别:
  • 资助金额:
    $34.96万
  • 财政年份:
    2015
  • 负责人:
    HALLGEIR RUI
  • 依托单位:
Prolactin pathways and metastatic progression of ER-positive breast cancer
  • 批准号:
    8888057
  • 项目类别:
  • 资助金额:
    $37.31万
  • 财政年份:
    2015
  • 负责人:
    HALLGEIR RUI
  • 依托单位:
Prolactin pathways and metastatic progression of ER-positive breast cancer
  • 批准号:
    9459853
  • 项目类别:
  • 资助金额:
    $34.95万
  • 财政年份:
    2015
  • 负责人:
    HALLGEIR RUI
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: